Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.
She has a BA in English language and literature from Rutgers University. You can connect with Julia on LinkedIn.
Mental Health, Immunizations, Sleep Focus of Barriers in Prevention and High-Value Care
June 28th 2022A panel held at the National Alliance of Healthcare Purchaser Coalitions Leadership Summits focused on mental health, immunizations, and sleep when speaking about the barriers to prevention and high-value care in these areas of medical coverage.
Read More
Chart-Based Visual Function Tests Limited in Detecting Intermediate AMD
June 28th 2022A noninterventional study found that chart-based assessments of visual function had adequate repeatability but were limited in discriminating between no age-related macular degeneration (AMD) and intermediate AMD.
Read More
Patients With COPD Prefer Improvement of Daily Symptoms Rather Than Exacerbations
June 27th 2022A discrete choice experiment found that patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) valued improvement in their daily symptoms more than improvement of exacerbations.
Read More
Influenza and PPSV23 Vaccines Evaluated for Their Ability to Stem COPD Exacerbations
June 25th 2022A cohort study found that influenza and 23-valent pneumococcal polysaccharide vaccines (PPSV23) can reduce the risk of chronic obstructive pulmonary disease (COPD)- and pneumonia-related hospitalizations.
Read More
Analysis Finds Ranibizumab PDS Cost-Saving in Long-term Scenarios
June 22nd 2022A recent study found that the ranibizumab port delivery system (PDS) has cost-saving potential compared with regular ranibizumab or aflibercept injections for age-related macular degeneration if used in the long term.
Read More
Intervention Can Help Decrease Exacerbation Rates, Improve Medication Adherence in COPD
June 15th 2022A recent study found that the Service Apothecary Respiratory Advice eHealth intervention could help patients with chronic obstructive pulmonary disease with exacerbation rates and medication adherence.
Read More
Vaping Injuries Associated With Long-term Respiratory Problems, Study Finds
June 9th 2022A new study found that patients with e-cigarette or vaping–associated lung injury had a higher risk of developing respiratory disability, cognitive impairment, symptoms of depression, anxiety, and posttraumatic stress within 1 year of their injury.
Read More
Study Finds Machine Learning Effective in Evaluating CKD Prognosis
June 7th 2022A retrospective study found that 3 machine learning models demonstrated equivalent predictability and greater sensitivity in the prognosis of chronic kidney disease (CKD) compared with the Kidney Failure Risk Equation.
Read More
Sacubitril/Valsartan Reduces mPAP, Improves Functional Capacity in HFpEF-PH
June 3rd 2022Sacubitril/valsartan reduced mean pulmonary artery pressure (mPAP) and improved lung congestion, functional capacity, and quality of life in a subset of patients with heart failure with preserved ejection fraction and pulmonary hypertension (HFpEF-PH) using a remote monitoring platform.
Read More